Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug testing and analysis

Showing results (131-140 of 2,762) with videos related to

Pageof 277
Sort By:
Drug Testing and Analysis|January 14, 2015
Genotoxicity of mesoporous silica nanoparticles in human embryonic kidney 293 cellsQuanan Zhang, Hanfeng Xu, Shengqin Zheng, et al.
Drug Testing and Analysis|August 11, 2015
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationshipsRebecca L Hartman, Timothy L Brown, Gary Milavetz, et al.
Drug Testing and Analysis|December 24, 2015
Screening and confirmation of a glycerol-positive caseKoen Deventer, Peter Van Eenoo
Drug Testing and Analysis|January 27, 2016
Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS<sup>n</sup> , and LC-HR-MS<sup>n</sup>Carina S D Wink, Julian A Michely, Andrea Jacobsen-Bauer, et al.
Drug Testing and Analysis|January 16, 2016
Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus projectMaren Hermanns-Clausen, Josephine Kithinji, Marco Spehl, et al.
Drug Testing and Analysis|October 13, 2015
Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sampleAdam T Cawley, Corrine Smart, Candace Greer, et al.
Drug Testing and Analysis|October 13, 2015
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Simon D Brandt, Pierce V Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis|October 28, 2014
Methylhexanamine is not detectable in Pelargonium or Geranium species and their essential oils: A multi-centre investigationMahmoud A ElSohly, Waseem Gul, Candice Tolbert, et al.
Drug Testing and Analysis|September 19, 2015
Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MSAndreas Thomas, Katja Walpurgis, Laura Tretzel, et al.
Drug Testing and Analysis|October 17, 2015
The in vivo and in vitro phase I metabolism of FYL-67, a novel oxazolidinone antibacterial drug, studied by LC-MS/MSZitai Sang, Haiyue Long, Tao Yang, et al.
Pageof 277

Showing results (131-140 of 2,762) with videos related to

Sort By:
Pageof 277
Drug Testing and Analysis|January 14, 2015
Genotoxicity of mesoporous silica nanoparticles in human embryonic kidney 293 cellsQuanan Zhang, Hanfeng Xu, Shengqin Zheng, et al.
Drug Testing and Analysis|August 11, 2015
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationshipsRebecca L Hartman, Timothy L Brown, Gary Milavetz, et al.
Drug Testing and Analysis|December 24, 2015
Screening and confirmation of a glycerol-positive caseKoen Deventer, Peter Van Eenoo
Drug Testing and Analysis|January 27, 2016
Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS<sup>n</sup> , and LC-HR-MS<sup>n</sup>Carina S D Wink, Julian A Michely, Andrea Jacobsen-Bauer, et al.
Drug Testing and Analysis|January 16, 2016
Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus projectMaren Hermanns-Clausen, Josephine Kithinji, Marco Spehl, et al.
Drug Testing and Analysis|October 13, 2015
Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sampleAdam T Cawley, Corrine Smart, Candace Greer, et al.
Drug Testing and Analysis|October 13, 2015
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Simon D Brandt, Pierce V Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis|October 28, 2014
Methylhexanamine is not detectable in Pelargonium or Geranium species and their essential oils: A multi-centre investigationMahmoud A ElSohly, Waseem Gul, Candice Tolbert, et al.
Drug Testing and Analysis|September 19, 2015
Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MSAndreas Thomas, Katja Walpurgis, Laura Tretzel, et al.
Drug Testing and Analysis|October 17, 2015
The in vivo and in vitro phase I metabolism of FYL-67, a novel oxazolidinone antibacterial drug, studied by LC-MS/MSZitai Sang, Haiyue Long, Tao Yang, et al.
Pageof 277